title: Is there evidence for post-translational modification of beta cell autoantigens in the aetiology and pathogenesis of type 1 diabetes?
abstract: Størling and colleagues hypothesise in this issue (Diabetologia DOI: 10.1007/s00125-013-3045-3 ) that post-translational modification (PTM) of autoantigens might create tissue-specific neo-epitopes that could trigger type 1 diabetes. Data on PTM of islet autoantigens are scarce and readers should not believe that the PTM hypothesis is supported by strong experimental evidence. The proposed genetic factors are many but their possible contribution is conjectural. There is a lack of a rational approach to test the PTM hypothesis at the different stages of type 1 diabetes. Research that carefully addresses each stage of the type 1 diabetes disease process is warranted to advance our understanding of autoimmune (type 1) diabetes.
authors.affiliation: Department of Clinical Sciences, Lund University/CRC, Skåne University Hospital SUS, Jan Waldenströms gata 35, SE-205 02, Malmö, Sweden, ake.lernmark@med.lu.se.
authors.forename: Ake
authors.initials: A
authors.lastname: Lernmark
references.citation: Diabetes Metab Res Rev. 2011 Nov;27(8):737-45
references.pmid: 22069253
references.citation: Diabetes. 2012 Oct;61(10):2556-64
references.pmid: 22787139
references.citation: Diabetologia. 2013 Aug;56(8):1705-1711
references.pmid: 23657799
references.citation: J Clin Endocrinol Metab. 2010 Jul;95(7):3360-7
references.pmid: 20444913
references.citation: Mol Membr Biol. 2009 Jan;26(1):42-54
references.pmid: 19169934
references.citation: Science. 1983 Dec 23;222(4630):1337-9
references.pmid: 6362005
references.citation: Diabetes. 2011 Jan;60(1):276-9
references.pmid: 20943747
references.citation: Diabetologia. 2008 May;51(5):846-52
references.pmid: 18373080
references.citation: Diabetologia. 1994 Apr;37(4):344-50
references.pmid: 8063033
references.citation: JAMA. 2013 Jun 19;309(23):2473-9
references.pmid: 23780460
references.citation: N Engl J Med. 1986 May 22;314(21):1360-8
references.pmid: 3517648
references.citation: Pediatr Diabetes. 2011 Dec;12(8):733-43
references.pmid: 21564455
references.citation: Cold Spring Harb Perspect Med. 2012 Apr;2(4):a007781
references.pmid: 22474615
references.citation: Clin Chem. 2011 Dec;57(12):1693-702
references.pmid: 21980171
references.citation: Lancet. 2004 Mar 20;363(9413):925-31
references.pmid: 15043959
references.citation: Diabetes Metab Res Rev. 2011 Nov;27(8):727-36
references.pmid: 22069252
references.citation: Diabetes. 2010 Dec;59(12):3174-80
references.pmid: 20858685
references.citation: Diabetes Care. 2013 Sep;36(9):2615-20
references.pmid: 23818528
references.citation: N Engl J Med. 2002 May 30;346(22):1685-91
references.pmid: 12037147
references.citation: Diabetes. 2002 May;51(5):1346-55
references.pmid: 11978629
references.citation: N Engl J Med. 2009 Apr 16;360(16):1646-54
references.pmid: 19369670
references.citation: Diabetologia. 2013 Nov;56(11):2347-54
references.pmid: 24048671
references.citation: PLoS One. 2011;6(10):e26931
references.pmid: 22046415